Validation experiment designed to validate causal mechanisms targeting CNR1,CAMK2A,GAD2,SLC17A6 in C57BL/6J mice (8-12 weeks old), GAD2-Cre-tdTomato mice, CB1R-floxed mice, CB1R-iCre-EGFP mice. Primary outcome: Sex-specific differences in cannabinoid-induced analgesia and mechanical allodynia
This study investigated sex-specific mechanisms of cannabinoid analgesia in neuropathic pain using a chronic constriction injury (CCI) model. The researchers examined the role of cannabinoid receptor 1 (CB1R) expressed on CaMKIIα neurons in the medial prefrontal cortex (mPFC) and their projections to the ventrolateral periaqueductal gray (vlPAG). Using viral tracing, immunohistochemistry, fluorescent in situ hybridization, RNAscope, conditional knockout, opto-XR, and electrophysiology approaches, they mapped CB1R expression patterns and investigated functional significance. The study focused on the mPFC-vlPAG circuit's role in descending pain inhibition and how CB1R deletion in this pathway affects pain sensitivity differently in male and female mice. The research revealed that deleting CB1R in the mPFCCaMKIIα-vlPAGGABA pathway causes severe pain in female mice and diminishes vlPAGvGlut2 inhibition, providing mechanistic insights into sex-specific cannabinoid analgesia.
Chronic constriction injury (CCI) model of sciatic nerve using 6-0 chromic gut sutures, viral tracing, immunohistochemistry, fluorescent in situ hybridization, RNAscope, conditional knockout, optogenetics, electrophysiology, behavioral pain testing
Female mice show superior analgesic responses to cannabinoids compared to males; CB1R deletion in mPFC-vlPAG pathway causes more severe pain in females; circuit-specific sex differences in synaptic plasticity and neurotransmitter release
Demonstration of sex-specific differences in cannabinoid analgesia, identification of CB1R expression patterns, functional validation of mPFC-vlPAG circuit role
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.